The WACC of Y-mAbs Therapeutics, Inc (YMAB) is 6.8%.
| Range | Selected | |
| Cost of equity | 7.60% - 12.20% | 9.90% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.6% - 7.9% | 6.8% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.8 | 1.32 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.60% | 12.20% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.6% | 7.9% |
| Selected WACC | 6.8% | |